Skip to main content
logo
Sernova Biotherapeutics Inc (TSX:SVA)
Canada flag Canada · Delayed Price · Currency is CAD
0.1100
-0.0050 (-4.35%)
Sep 4, 2026, 3:10 PM EST

Sernova Biotherapeutics Ratios and Metrics

Millions CAD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Market Capitalization
425981244234326
Market Cap Growth
-29.65%-27.14%-66.65%3.99%-28.16%491.44%
Enterprise Value
556477213193297
Last Close Price
0.110.150.250.760.801.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PB Ratio
-4.31-2.36-6.2819.494.9311.63
P/TBV Ratio
---19.994.9811.93

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Debt / Equity Ratio
-0.25-0.19-0.040.010.010.01
Net Debt / Equity Ratio
-0.14-0.180.42-1.57-1.04-0.98
Net Debt / EBITDA Ratio
-0.14-0.300.170.492.024.11
Net Debt / FCF Ratio
-0.25-0.410.290.653.364.01
Quick Ratio
0.110.020.322.1710.7419.19
Current Ratio
0.140.020.322.1910.7819.19
Return on Equity (ROE)
----129.72%-64.54%-43.25%
Return on Assets (ROA)
-238.26%-226.48%-133.56%-67.87%-37.59%-24.39%
Return on Capital Employed (ROCE)
109.50%62.50%253.60%-323.60%-51.80%-24.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Earnings Yield
-28.66%-26.57%-39.58%-15.99%-10.41%-2.13%
FCF Yield
-13.24%-18.41%-23.23%-12.48%-6.29%-2.10%
Buyback Yield / Dilution
-5.28%-6.95%-1.19%-10.87%-11.43%-24.45%